Cargando…
SAT365 Prevalence of Polycystic Ovary Syndrome (PCOS) in Health System and Insurer Records vs. the Prevalence in the Population: Evidence for the Significant Underdiagnosis and Undertreatment of PCOS
Disclosure: S. Hatoum: None. M. Amiri: None. D. Hopkins: None. R.P. Buyalos: Employee; Self; Fertility & Surgical Associates of California. F. Bril: None. R. Azziz: Advisory Board Member; Self; Arora Forge. Consulting Fee; Self; Rani Therapeutics, Fortress Biotech, Spruce Biosciences, Core Acces...
Autores principales: | Hatoum, Sana, Amiri, Mina, Hopkins, Dawnkimberly, Buyalos, Richard P, Bril, Fernando, Azziz, Ricardo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10554694/ http://dx.doi.org/10.1210/jendso/bvad114.1670 |
Ejemplares similares
-
SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study
por: Amiri, Mina, et al.
Publicado: (2023) -
SAT363 The Prevalence And Phenotype Of Polycystic Ovary Syndrome (PCOS) In A Community-Based Population In Sub-Sahara Africa: The Nigeria-PEP Study
por: Makwe, Christian Chigozie, et al.
Publicado: (2023) -
SAT374 Indirect and Intangible Burden of PCOS: A Patient Advocacy Organization Study
por: Thai, Linda, et al.
Publicado: (2023) -
SAT370 Economic Burden of Endometrial Cancer Associated with Polycystic Ovary Syndrome
por: Pace, Lauren Arielle, et al.
Publicado: (2023) -
SAT-004 Prevalence of Abnormalities of Glucose Metabolism in Teenage Indian Girls with PCOS
por: Talwar, Vipan
Publicado: (2020)